Dog · Canis lupus familiaris · typical adult weight 2.00–80.00 kg
Medetomidine-Vatinoxan is used in dogs for Sedation with improved hemodynamics. Routes documented in dogs: IM. A typical adult dog weighs 2.00–80.00 kg. ExoticRx lists 1 cited dose rule for Medetomidine-Vatinoxan in dogs, drawn from published veterinary references. Verify against current literature before clinical use.
US trade names: Zenalpha
| Route | Dose | Frequency | Duration | Indication | Evidence | Source |
|---|---|---|---|---|---|---|
| IM | FDA-approved for dogs | Single dose (weight-based) | 30-60 min sedation; reversible | Sedation with improved hemodynamics | Strong | ZENALPHA- Vatinoxan Hydrochloride and Medetomidine Hydrochloride Solution [US Product Label for Dogs]. Dechra Veterinary Products; 2021. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=623f44bf-07c7-4704-8114-5e42e1316fb1 — Verified against Plumb's Veterinary Drug Handbook, 10th Ed, p.840 (2026-08-01). |
Need the exact dose for your patient?
Enter your dog's weight to check these cited ranges in the calculator — unit and concentration math done for you.
Medetomidine provides alpha-2 mediated sedation and analgesia; vatinoxan blocks peripheral alpha-2 effects to maintain cardiac output and tissue perfusion.
Dogs only (FDA-approved). Reduced bradycardia compared to medetomidine alone. Reversible with atipamezole for central effects. Improved hemodynamic profile.
Species-specific contraindications and adverse-reaction reports for dogs may differ from canine / feline reference data — consult the primary citations listed with each rule.
Medetomidine-Vatinoxan dose range in dogs, with cited source references: IM FDA-approved for dogs Single dose (weight-based). Reference ranges from cited sources — verify against current literature before clinical use.
Documented routes for Medetomidine-Vatinoxan in dogs: IM.
Cited course lengths for Medetomidine-Vatinoxan in dogs include: 30-60 min sedation; reversible. Duration depends on the indication — match it to the specific dose rule in the table above.
Medetomidine-Vatinoxan is indicated in dogs for: Sedation with improved hemodynamics.
These are general warnings for Medetomidine-Vatinoxan across species; consult the dog dosing table above for species-specific guidance. Dogs only (FDA-approved). Reduced bradycardia compared to medetomidine alone. Reversible with atipamezole for central effects. Improved hemodynamic profile.
Why a species-specific page? Medetomidine-Vatinoxan pharmacokinetics differ across species: dose ranges, intervals, and route preferences are not interchangeable. Cross-extrapolation from canine doses is unsafe in dogs — the rules above are the citations specific to this species, not generic recommendations.
Sourced from published veterinary references; awaiting credentialed clinical reviewer. See our editorial process. Reference only — not veterinary advice.